FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012872012> ?p ?o ?g. }

• W2012872012 endingPage "19" @default.
• W2012872012 startingPage "8" @default.
• W2012872012 abstract "Recent clinical studies indicate that intravascular brachytherapy (IVB) can reduce the rate of restenosis substantially after angioplasty procedures. However, no clinical guidelines exist for optimal therapy.The members of the IVB Subcommittee of the American Brachytherapy Society (ABS) identified the areas of consensus and controversies in IVB to issue the ABS perspective on IVB, based on analysis of published reports and the clinical experience of the members in brachytherapy.IVB is still experimental. The long-term efficacy, toxicity, the target tissue, and dose required for IVB are not established. The ABS recommends that IVB procedures must be performed, with careful attention to radiation-related issues, in the context of controlled multidisciplinary clinical trials with the approval of the institutional review board, the Nuclear Regulatory Commission, the Food and Drug Administration, and under an Investigational Device Exemption. The therapeutic radiologist, with a qualified radiation physicist, is responsible for dose prescription and delivery and needs to be present during the IVB procedure as part of this multidisciplinary team. The long-term outcome from these studies should be reviewed critically and published in peer-reviewed journals. The ABS endorsed the dosimetric guidelines of the American Association of Physicists in Medicine Task Group 60 (AAPM TG-60) report. The ABS recommends that dose specification be defined clearly; to allow comparisons between studies, the dose should be prescribed at 2 mm from the source for intracoronary brachytherapy and at an average luminal radius of +2 mm for peripheral vascular brachytherapy. The prescription doses at the above point is generally in the 12-18 Gy range. Comprehensive procedures for quality assurance, radiation protection, and emergencies should be in place before initiating an IVB program. Higher energy beta sources, lower energy gamma sources, dose-volume histograms, and correlation of three-dimensional reconstructions of delivered dose with patterns of failure are areas for further research.The ABS perspective on IVB is presented to assist the interventional team in developing protocols for the use of IVB in the prevention of restenosis. Long-term outcome data with a standardized reporting system are needed to establish the role of brachytherapy in preventing vascular restenosis. Endovascular brachytherapy is a new and evolving modality, and these recommendations are subject to modifications as new data become available." @default.
• W2012872012 created "2016-06-24" @default.
• W2012872012 creator A5002279235 @default.
• W2012872012 creator A5002406071 @default.
• W2012872012 creator A5016594403 @default.
• W2012872012 creator A5024834771 @default.
• W2012872012 creator A5026579804 @default.
• W2012872012 creator A5027202861 @default.
• W2012872012 creator A5027743076 @default.
• W2012872012 creator A5031969152 @default.
• W2012872012 creator A5032752677 @default.
• W2012872012 creator A5033578637 @default.
• W2012872012 creator A5054955881 @default.
• W2012872012 creator A5059024391 @default.
• W2012872012 creator A5072521144 @default.
• W2012872012 creator A5084865929 @default.
• W2012872012 creator A5089288351 @default.
• W2012872012 date "1999-01-01" @default.
• W2012872012 modified "2023-10-18" @default.
• W2012872012 title "The american brachytherapy society perspective on intravascular brachytherapy" @default.
• W2012872012 cites W1967871319 @default.
• W2012872012 cites W1971750742 @default.
• W2012872012 cites W1976689239 @default.
• W2012872012 cites W1982560810 @default.
• W2012872012 cites W1988053612 @default.
• W2012872012 cites W2002935714 @default.
• W2012872012 cites W2004466315 @default.
• W2012872012 cites W2013287436 @default.
• W2012872012 cites W2014261851 @default.
• W2012872012 cites W2017944375 @default.
• W2012872012 cites W2022536824 @default.
• W2012872012 cites W2023205904 @default.
• W2012872012 cites W2026338515 @default.
• W2012872012 cites W2026581670 @default.
• W2012872012 cites W2032014961 @default.
• W2012872012 cites W2034653150 @default.
• W2012872012 cites W2038494019 @default.
• W2012872012 cites W2041036434 @default.
• W2012872012 cites W2041445228 @default.
• W2012872012 cites W2050360243 @default.
• W2012872012 cites W2051904824 @default.
• W2012872012 cites W2056760734 @default.
• W2012872012 cites W2059779779 @default.
• W2012872012 cites W2060374101 @default.
• W2012872012 cites W2068385607 @default.
• W2012872012 cites W2070816545 @default.
• W2012872012 cites W2071407807 @default.
• W2012872012 cites W2075287856 @default.
• W2012872012 cites W2076190708 @default.
• W2012872012 cites W2103301864 @default.
• W2012872012 cites W2107392339 @default.
• W2012872012 cites W2114068102 @default.
• W2012872012 cites W2114092423 @default.
• W2012872012 cites W2125399536 @default.
• W2012872012 cites W2127298401 @default.
• W2012872012 cites W2142737221 @default.
• W2012872012 cites W2164014979 @default.
• W2012872012 cites W2330609598 @default.
• W2012872012 cites W2339020512 @default.
• W2012872012 cites W2398775255 @default.
• W2012872012 cites W2471561657 @default.
• W2012872012 cites W3203588132 @default.
• W2012872012 doi "https://doi.org/10.1016/s1522-1865(98)00003-1" @default.
• W2012872012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11272360" @default.
• W2012872012 hasPublicationYear "1999" @default.
• W2012872012 type Work @default.
• W2012872012 sameAs 2012872012 @default.
• W2012872012 citedByCount "19" @default.
• W2012872012 countsByYear W20128720122012 @default.
• W2012872012 crossrefType "journal-article" @default.
• W2012872012 hasAuthorship W2012872012A5002279235 @default.
• W2012872012 hasAuthorship W2012872012A5002406071 @default.
• W2012872012 hasAuthorship W2012872012A5016594403 @default.
• W2012872012 hasAuthorship W2012872012A5024834771 @default.
• W2012872012 hasAuthorship W2012872012A5026579804 @default.
• W2012872012 hasAuthorship W2012872012A5027202861 @default.
• W2012872012 hasAuthorship W2012872012A5027743076 @default.
• W2012872012 hasAuthorship W2012872012A5031969152 @default.
• W2012872012 hasAuthorship W2012872012A5032752677 @default.
• W2012872012 hasAuthorship W2012872012A5033578637 @default.
• W2012872012 hasAuthorship W2012872012A5054955881 @default.
• W2012872012 hasAuthorship W2012872012A5059024391 @default.
• W2012872012 hasAuthorship W2012872012A5072521144 @default.
• W2012872012 hasAuthorship W2012872012A5084865929 @default.
• W2012872012 hasAuthorship W2012872012A5089288351 @default.
• W2012872012 hasConcept C126838900 @default.
• W2012872012 hasConcept C151730666 @default.
• W2012872012 hasConcept C19527891 @default.
• W2012872012 hasConcept C2777416452 @default.
• W2012872012 hasConcept C2779343474 @default.
• W2012872012 hasConcept C509974204 @default.
• W2012872012 hasConcept C71924100 @default.
• W2012872012 hasConcept C86803240 @default.
• W2012872012 hasConceptScore W2012872012C126838900 @default.
• W2012872012 hasConceptScore W2012872012C151730666 @default.
• W2012872012 hasConceptScore W2012872012C19527891 @default.
• W2012872012 hasConceptScore W2012872012C2777416452 @default.
• W2012872012 hasConceptScore W2012872012C2779343474 @default.

• next